Telesis Bio, Inc. (TBIO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TBIO
- Company Telesis Bio, Inc.
- Price $0.39
- Changes Percentage 37.72
- Change 0.106
- Day Low $0.28
- Day High $0.39
- Year High $15.46
- Year Low $0.25
- Market Cap $687,250
- Price Avg 50 EMA (D) $0.5
- Price Avg 200 EMA (D) $2.77
- Exchange NASDAQ
- Volume 3
- Average Volume 6,706
- Open $0.28
- Previous Close $0.28
- EPS -30.42
- PE -0.01
- Earnings Announcement 2025-03-26 10:59:00
- Shares Outstanding $1,775,840
Company brief: TELESIS BIO, INC. (TBIO )
- Healthcare
- Medical - Devices
- Mr. Eric Esser
- https://codexdna.com
- US
- N/A
- 06-18-2021
- US1920031010
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.